Real-world comparison of axi-cel and tisa-cel in DLBCL
Real-world evidence data have confirmed the efficacy and safety of axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel). This updated PSM analysis aimed to assess outcomes in a larger cohort of patients with DLBCL over a longer follow-up period.